Darolutamide Tied to Symptom Control in Non-Metastatic Prostate Cancer Analysis of ARAMIS trial results also shows QoL benefits with androgen receptor inhibitor Sep 12, 2021
9/11 Responders Face Higher Risk of Multiple Cancers Longer follow-up sheds light on the long-term consequences of exposure to disaster site Sep 10, 2021
PSMA PET Plus MRI Better Detects Clinically Significant Prostate Cancers Increase in negative predictive value and improved sensitivity versus MRI alone Sep 01, 2021
ADT Options for Prostate Cancer Come Out Even for Heart Safety But low enrollment brought PRONOUNCE trial to an early close Aug 31, 2021
Robot-Assisted Prostatectomy Tied to Fewer Complications Taiwan study also saw shorter hospital stays versus open or laparoscopic surgeries Aug 25, 2021
When Is ADT Right for Biochemically Recurrent Prostate Cancer? Study findings suggest early initiation may not "meaningfully" improve survival outcomes Aug 09, 2021
Support for MRI-Targeted Biopsy in Prostate Cancer Screening Large Swedish study showed the approach cut overdiagnosis, unnecessary biopsies Jul 09, 2021
Could Docetaxel Have Role in Unfavorable-Risk Prostate Cancer? Use of chemo reduced radiation-induced cancers, and may prolong OS in low-PSA subgroup Jul 07, 2021
Do 'Robots' Offer Any Clear Surgical Advantage? Review says no, and Vinay Prasad believes it's a sobering reflection on medical technology Jun 28, 2021 video
AI for Radiation Therapy Works, but Is it Fully Trusted? Most machine learning-generated plans selected over human plans in head-to-head comparison Jun 16, 2021
What's Guiding Prostate Cancer Care for Gay Men? Research specific to this group has only scratched the surface Jun 16, 2021
COVID Vaccine Protection; 'Until You Die From the Cancer'; What's Palliative Care? News, features, and commentary about cancer-related issues Jun 10, 2021
New Standard for Metastatic Castration-Sensitive Prostate Cancer? Triplet regimen reduced the risk for radiographic progression or death, but OS data await Jun 09, 2021
BPAs Cut Fracture Risk in Metastatic Prostate Cancer Those receiving enzalutamide with and without radium-223 saw benefits in updated safety analysis Jun 08, 2021
Radioligand Therapy Boosts Survival in Metastatic CRPC PSMA-directed agent improved overall survival by median 4 months Jun 04, 2021
With Supplements, ADT in Prostate Cancer of Little Threat to Bone Density Study suggests calcium/vitamin D alone sufficient for long-duration therapy Jun 03, 2021
Vaccination, Screening Succeeds in Cervical and Prostate Cancers Cervical cancer rates on the decline; PSA testing benefits younger Black men May 19, 2021
SBRT Safe for Cancer Patients With Multiple Metastases Late adverse events in phase I trial indicate need for extended follow-up May 03, 2021
Treatment Type a Non-Factor in Prostate Cancer Patients' Anxiety Researchers emphasized importance of psychological interventions as problems arise Apr 29, 2021
Late ADT a Problem in Prostate Cancer Late dosing of LHRH agonists happens too frequently, researchers report Apr 22, 2021
No More Men Need to Die From Transrectal Prostate Biopsies A movement toward transperineal biopsies Apr 21, 2021
More Benefit With Taxane for Aggressive Metastatic Prostate Cancer Higher clinical benefit rate with front-line cabazitaxel versus androgen receptor inhibitor Apr 12, 2021
Mixed Results for Immunotherapy in Metastatic Prostate Cancer Combination trial missed response endpoint but exceeded historical results Apr 11, 2021
CCR Score Could Offer ADT-Free Path in Higher-Risk Prostate Cancer Large proportion of intermediate- to high-risk patients could avoid aggressive therapy Feb 12, 2021
Radionuclide Tx Wins in Third-Line Metastatic CRPC Early trial shows improved PFS, response rates versus cabazitaxel Feb 11, 2021
Hit and Miss in Castration-Resistant Prostate Cancer No OS benefit with apalutamide-abiraterone, despite improved PFS Feb 11, 2021
Brain Tumor Risk Upped With Synthetic Progestogen Absolute risk still low, however, and product not currently approved in U.S. Feb 03, 2021
Whole-Pelvis Tops Prostate-Only RT in High-Risk Disease Practice impact may hinge on knowledge versus clinical bias Jan 28, 2021
Is This Really Cancer? Movement builds to classify Gleason 6 prostate lesions as nonmalignant Jan 09, 2021
PARP Inhibitors Linked With Blood Cancer Risk Incidence of MDS/AML under 1%, but further investigation warranted as indications broaden Dec 28, 2020
High-Risk Prostate Cancer Patients Can Wait 6 Months for Surgery: Study Can be considered low priority procedure during COVID-19 pandemic, researchers say Dec 08, 2020
FDA OKs 'Game Changer' Radiotracer for Prostate Cancer PET imaging drug detected metastasis at initial diagnosis, outperformed standard for PSA recurrence Dec 01, 2020
Al Roker's Prostate Cancer Morning show stalwart's diagnosis highlights discrepancies for Black men Nov 10, 2020
Focal RT Boost in High-Risk Prostate Cancer Cuts PSA Relapse Rates of biochemical relapse cut in half with boost to 95 Gy Oct 29, 2020
COVID-19 in Health Workers; Stimulating New White Blood Cells: It's TTHealthWatch! This week's topics also include gene expression and COVID infection, and outbreaks in childcare settings Sep 19, 2020 podcast
Surgery Rates Doubled for High-Risk Prostate Cancer Use of prostatectomy nearly equaled radiotherapy in 2016 Aug 31, 2020
Lower COVID-19 Risk With ADT for Prostate Cancer Higher risk of infection, more severe disease in men who did not receive hormones Aug 14, 2020
The Serious Conversation: Delivering Bad News by Telemedicine As office visits move online, clinicians discuss breaking life-changing diagnoses virtually Jul 13, 2020
Oral ADT Slashes Heart Risk in Advanced Prostate Cancer Novel GnRH antagonist has potential to be new standard, says researcher May 30, 2020
